LMB, ZUMZ and MHO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 6, 2024.
Limbach (LMB) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here is how Limbach (LMB) and Genpact (G) have performed compared to their sector so far this year.
Limbach (LMB) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Limbach (LMB) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.46 per share a year ago.
Limbach Holdings is experiencing topline weakness due to revenue loss in the GCR segment, targeting ODR revenue share increase to drive EBITDA growth. Continued investment in acquisition and new product offerings should drive topline growth in coming years. LMB's valuation is currently near its sector median and considering promising long-term prospects, the stock is a decent buy at the current levels.
Limbach Holdings stock has increased by 92% since my very first bullish call in June 2023, outperforming the S&P 500 Index. As far as I can see, the company continues to grow EBITDA and EPS by focusing on higher-margin businesses. Management is raising its forecast for adjusted EBITDA, which could indicate that margins are growing even faster than previously assumed.